Monsanto owner Bayer AG is backing away from a plan to contain future Roundup cancer claims after a federal judge made it clear he would not approve the scheme, which would delay new trials and limit jury decision-making. The plan concocted by Bayer and a small group of lawyers was filed last month in U.S. … Continue reading Bayer backs away from plan to contain future Roundup cancer claims